Antigen escape in CAR ‐T therapy: A tumor microenvironment perspective from hematological to solid tumors
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70117 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Shuai Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Tumor Escape, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 135 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Chimeric antigen receptor T‐cell (CAR‐T) therapy has shown remarkable efficacy in hematologic malignancies, but antigen escape remains a major challenge, especially in solid tumors, where the tumor microenvironment (TME) exacerbates the problem. Mechanisms of antigen escape include antigen loss, epitope masking, lineage switching, and trogocytosis‐mediated CAR dysfunction. The TME promotes immune evasion through physical barriers, immunosuppressive cells, and metabolic competition. To overcome these challenges, multi‐targeted CAR‐Ts, gene editing, epigenetic interventions, and combination therapies have been developed to enhance CAR‐T efficacy. Emerging strategies—such as microbial‐guided antigen labeling, nanotechnology for metabolic normalization, armored CAR‐T secreting TME‐modulating agents, and adaptive CAR systems responsive to TME signals—offer new solutions to target “cold” tumors. Future breakthroughs will rely on synergizing dynamic CAR systems for broad antigen coverage, achieved via multi‐targeting and non‐canonical antigen recognition, with engineered TME remodeling driven by microbial, viral, and immune cell allies, as well as armored CAR‐T cells secreting immunomodulators. Combined with metabolic engineering and interdisciplinary innovation, this integrated approach will effectively enable CAR‐T cells to orchestrate a multi‐faceted anti‐tumor ecosystem rather than functioning in isolation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China.
ORCID-Profile: Shuai Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, S., Li, W., Li, J., Guo, Z., Chen, J., & Hu, Z. (2026). Antigen escape in CAR ‐T therapy: A tumor microenvironment perspective from hematological to solid tumors. International Journal of Cancer. https://doi.org/10.1002/ijc.70117
Vancouver
Wang S, Li W, Li J, Guo Z, Chen J, Hu Z. Antigen escape in CAR ‐T therapy: A tumor microenvironment perspective from hematological to solid tumors. International Journal of Cancer. 2026. doi:10.1002/ijc.70117
BibTeX
@article{Wang2026,
author = {Wang, Shuai and Li, Wenying and Li, Jiayi and Guo, Zhigang and Chen, Jiannan and Hu, Zhigang},
title = {Antigen escape in CAR ‐T therapy: A tumor microenvironment perspective from hematological to solid tumors},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70117}
}
EUVIMED